N/A
Completed N=46
Quadratus Lumborum Block for Analgesia Following Hip Arthroscopy
Surgery
Source: ClinicalTrials.gov NCT03557125 ↗
Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcomePrimary: Opioid Consumption — 8.1; 11.3 Morphine Milligram Equivalents
Summary
Evaluate difference in postoperative opiate consumption when patients do or do not receive a quadratus lumborum block preoperatively for hip arthroscopy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Opioid Consumption |
8.1; 11.3 | — |
| SECONDARY Visual Analog Pain |
58.6; 59.6 | — |
| SECONDARY Visual Analog Scale at Time of Post Anesthesia Care Unit Discharge |
57.9; 59.2 | — |
| SECONDARY Post Anesthesia Care Unit Duration |
99.9; 110.3 | — |
| SECONDARY Patient Satisfaction |
7.5; 8.6 | — |
| SECONDARY Opioid Related Side Effects |
9; 10 | — |
| SECONDARY Duration of Nerve Block |
955.7; 105 | — |
Eligibility Criteria
Inclusion Criteria
- Age greater than or equal to 18 years-old
- Undergoing elective hip arthroscopy. Exclusion Criteria
- Local anesthetic allergy
- Chlorhexidine allergy
- Patient weight < 40kg
- Patient is currently pregnant
- Patient is unable or chooses not to give informed consent
- Emergency surgery
- Known preoperative substance abuse
- Preoperative opioid use for over three months
Data sourced from ClinicalTrials.gov (NCT03557125). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.